© 1995 American Heart Association, Inc.
Articles |
Glycosphingolipid Accumulation in the Aortic Wall Is Another Feature of Human Atherosclerosis
From the Institute of Experimental Cardiology, Cardiology Research Center, Russian Academy of Medical Sciences, Moscow, Russia (D.N.M.), and the Section of Experimental Atherosclerosis, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (F.-F.C., H.S.K.).
Correspondence to Dr Howard S. Kruth, Section of Experimental Atherosclerosis, NHLBI, NIH, Bldg 10, Rm 5N113, 10 Center Dr MSC 1422, Bethesda, MD 20892-1422.
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Abstract High accumulation of lipids is a typical feature of an atherosclerotic lesion. We have previously identified the chemical structure of the major glycosphingolipids (GSLs) of human aorta; however, quantification of the absolute concentration of GSLs was not carried out. In the present study, for the first time we have performed a quantitative comparative analysis of GSL composition in the media and two sublayers of the intima taken from normal regions, fatty streaks, and atherosclerotic plaques of the human aorta. The intimal tissue containing fatty streaks and atherosclerotic plaques accumulated GSLs, predominantly glucosylceramide (GlcCer), lactosylceramide (LacCer), and ganglioside GM3. GSL levels in plaques were highest: GlcCer was 18- and 8-fold, LacCer was 8- and 7-fold, and GM3 was 2.5- and 12-fold higher than in musculoelastic and elastic-hyperplastic intimal layers of normal regions, respectively. We did not observe a significant increase in other GSLs. An increase in the content of gangliosides GD3 and GD1a was detected in the media underlying atherosclerotic lesions. On the basis of an analysis of the ratio of GlcCer, LacCer, and GM3 accumulated in the tissue and cells of the elastic-hyperplastic layer of intima, we have concluded that the accumulation of the above-mentioned GSLs occurs mainly in the extracellular space of the intima. In this study, we have also demonstrated that extracellular lipid liposomes, which appear in the early stages of atherogenesis, are one locus of GSL accumulation in the extracellular space of the intima. The findings suggest that the GSL concentration and distribution within the normal and atherosclerotic aorta reflects a number of factors that include (1) synthesis of GSLs within the vessel wall, (2) deposition of GSLs within the vessel wall from plasma-derived lipoproteins, (3) the degree of association of the various GSLs with intimal cells as well as extracellular lipid particles, and (4) metabolic relationships between cholesterol and GSL accumulation.
Key Words: atherosclerosis • aorta • glycosphingolipids • extracellular lipid particles • gangliosides
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
High accumulation of lipids in the intima of the major arteries is a typical feature of atherosclerotic lesions. Lipid accumulation occurs both in cells and in the extracellular spaces of the intima. Cholesterol has long been known to be the major lipid component accumulating in atherosclerotic lesions,1 and many studies have been devoted to the role of cholesterol in the formation of atherosclerotic lesions. However, the mechanism of initiation and progression of atherosclerotic lesions is still unclear. Much less attention has been paid to the accumulation of minor lipid components in atherosclerotic lesions. These lipids may influence processes that contribute to the development of atherosclerotic lesions.2 3 Some previous studies specifically focused on GSL accumulation in arteries during human atherosclerosis and experimental atherosclerosis in animals.4 5 6 7 Earlier studies identified the chemical structure of the major GSLs of human aorta8 9 and showed that GSLs accumulate in the intimal cells of aortic atherosclerotic lesions.10 11 However, quantification of the absolute concentration of GSL species in unlesioned and atherosclerotic aortas was not carried out.
We have now undertaken a more detailed study to investigate changes in GSL composition in human atherosclerotic aorta. In this study, for the first time we have quantified the concentration of GSLs accumulated in atherosclerotic tissues and compared the GSL composition of the media and the elastic-hyperplastic and musculoelastic layers of the intima. Comparison of the degree of GSL accumulation in the whole tissue and enzymatically isolated aortic cells suggested to us that much GSL accumulated extracellularly in the intima. Early stages of atherogenesis are characterized by the appearance of extracellular lipid particles that are known to be a locus of extracellular cholesterol accumulation.12 13 14 15 16 17 18 19 20 Two types of these particles have been described: esterified cholesterol–rich droplets and unesterified cholesterol–rich multilamellar liposomes.21 We have explored the possibility that these lipid particles are a locus not only of extracellular cholesterol accumulation but also of extracellular GSL accumulation in human atherosclerotic lesions.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Preparation of Aortic Tissue Samples for GSL Analysis
Aorta samples were taken aseptically 1.5 to 3 hours after death from 40- to 60-year-old subjects who had died suddenly of myocardial infarction or some other cause. The samples were kept frozen until analysis. Upon being thawed, the vessels were cut longitudinally and the types of atherosclerotic lesions were assessed according to the classification suggested by Smith.22 Two types of lesions were analyzed in the study: (1) fatty streaks, strips 2 to 3 mm wide and 5 to 30 mm long, slightly elevated over the vessel surface, and (2) atherosclerotic plaques, lesions highly elevated over the luminal surface, usually of rounded shape, light yellow or pearl in color. Only uncomplicated plaques that were not ulcerated, thrombosed, or calcified were used for the study. Regions of aorta that were without macroscopic lesions and that did not stain with Sudan IV were regarded as normal unaffected aortic tissue. Regions of normal aortic tissue and areas affected by fatty streaks or atherosclerotic plaques were excised, and tissue of each type of lesion (each aorta contained a mixture of fatty streaks and plaques) was pooled. Tissue was processed further as described below.
Human adult aortic intima, as well as coronary artery intima, is known to consist of two major layers.23 24 25 The musculoelastic layer adjacent to the media is separated from it by an internal elastic lamina, and is separated from the layer adjacent to the lumen (ie, the elastic-hyperplastic layer) by a secondary elastic lamina. To extend our previous work10 11 25 we examined the GSL composition in each of the two intimal layers separately. For each type of aortic tissue (normal or lesioned), the intima was separated along the main elastic membranes from the media, and the intimal musculoelastic layer was separated from the intimal elastic-hyperplastic layer with the aid of forceps. The accuracy of the procedure was verified for each specimen by light microscopy according to Smith et al15 with partially stripped tissue samples that were stained for Verhoeff's elastic, as illustrated previously.25 The detachment of the intima from the media and of the elastic-hyperplastic layer from the musculoelastic layer was considered faulty if it occurred above or beneath these membranes. Such tissue preparations were discarded. In some cases, the elastic-hyperplastic layer contained a third, external connective tissue layer. However, it was usually difficult to establish the marginal line between these two layers, and therefore this connective tissue layer was left intact in the preparation of the elastic-hyperplastic layer. For convenience, we shall henceforth refer to the musculoelastic intimal layer as muscular and to the layer that includes the elastic-hyperplastic and connective tissue layers as hyperplastic. The lipid core (if any) localized within the hyperplastic layer, leaving intact the muscular layer. Only in complicated plaques did the necrotic zone involve the muscular layer of intima. In such plaques it was impossible to separate the two intimal layers correctly, and these preparations were discarded.
We performed three independent experiments, each time taking tissue from 5 to 8 aortas.
Isolation and Purification of Aortic Lipid Particles
Aortic tissue specimens from three different aortas for lipid
particle isolation were obtained 5 to 10 hours after death, stored in
Leibovitz 15 medium26 (Hazleton Laboratory) for transport
to the laboratory, and frozen in this medium within 24 hours of
autopsy. Tissues from each aorta contained a mixture of fatty streaks
and plaques. Aortic lipid particles were isolated from the entire
intima as described previously.21 The aortic tissues were
thawed at 4°C, rinsed several times in chilled D-PBS, and dissected
free of adventitia and media. The intimal tissues were then rinsed in
D-PBS, blotted dry, and weighed. The tissues were minced for
approximately 30 minutes with scissors in 0.15 mol/L NaCl (pH 7.4)
containing 0.1% EDTA, 0.05% glutathione, and 0.02% NaN3
(1 g tissue per 8 mL solution). The majority of the minced pieces were
less than 1 mm3 in size. These and all subsequent
procedures were carried out at 4°C.
The lipid-containing supernatant was collected after a low-speed centrifugation (1500g for 15 minutes) of the minced tissue. This sample was then passed through low-protein–binding polysulfone 0.45-µm (pore size) filters (Acrodisc 4184, Gelman Sciences) to remove crystalline lipid and lipid droplets. The filtrate was concentrated to 2 to 3 mL in an Amicon stirred cell by use of a cellulosic filter with a molecular weight cutoff of 10 000 (YM-10, Amicon). Next, the filtrate was dialyzed overnight against 4 L of 1.5 mol/L NaCl (pH 7.4) containing 0.1% EDTA, 0.05% glutathione, and 0.02% NaN3. The dialysate was subjected to gel-filtration column chromatography (Bio-Gel, A-50m) with a 1.6x50-cm column eluted at a flow rate of 7 mL · hr-1 · cm-2 with the same solution that was used for dialysis.
Density gradient centrifugation of the pooled void volume fractions was carried out in a Beckman Ultraclear tube centrifuged in a Beckman SW-41 rotor. A discontinuous gradient was constructed from bottom to top with NaCl solutions: 3 mL at d=1.100 g/mL, 3 mL of void volume fraction at d=1.063 g/mL, 3 mL at d=1.019 g/mL, and 2.5 mL at d=1.006 g/mL. All salt solutions were at pH 7.0 and contained 0.1% EDTA and 0.01% thimerosal. The gradient was centrifuged for 22 hours at 170 000g. During the centrifugal procedure, a continuous gradient was formed as described by Redgrave et al.27 After centrifugation, an esterified cholesterol–rich lipid fraction was collected at d<1.01 g/mL and an unesterified cholesterol–rich lipid fraction was collected at density limits between 1.03 and 1.05 g/mL.
Isolation of Plasma LDL
LDLs (d=1.019 to 1.065 g/mL) were isolated from the
plasma of three male patients (40 to 60 years old) with
coronary heart disease and angiographically documented
stenosis of the coronary arteries. LDLs were isolated
by sequential flotational ultracentrifugation
according to Lindgren.28 Each
ultracentrifugation was performed at 10°C in a 60
Ti rotor (Beckman) for 18 to 20 hours at 105 000g. The
final LDL preparation from each patient was washed once at its higher
limiting (solvent) density and was then exhaustively dialyzed at 4°C
against a solution containing 0.15 mol/L NaCl, 0.01%
NaN3, and 0.01% EDTA at pH 7.4.
Isolation of Aortic Cells
Cells were isolated from human aortic hyperplastic intimal
layers of grossly unlesioned or atherosclerotic plaque tissue by
digestion with Medium 199 containing 0.1% collagenase
(Type II, Worthington Diagnostic System Inc), 10% fetal
calf serum, 100 g/mL streptomycin, and 2.5 g/mL fungizone (all
purchased from Grand Island Biological Co), as described
previously.10 11 25 29 30 The viability of the isolated
cells determined with trypan blue was 85% to 90%. The isolated cells
were extracted immediately after the isolation. Cells isolated from 10
aortas were pooled. The pooled cell samples contained about
2.0x107 cells.
Chemical Analysis of Cholesterol
Lipids of the aortic tissue and isolated aortic lipid particles,
aortic intimal cells, and LDLs were extracted with chloroform/methanol
(2:1, vol/vol).31 Unesterified and esterified
cholesterol were determined enzymatically with a
fluorometric method32 for tissue and lipid particles and
with a calorimetric method by use of the Monotest kit
(Boehringer Mannheim GmbH) for aortic cells and LDLs.
Isolation and Purification of GSLs
Aortic tissue samples (1 to 32 g wet tissue) were
homogenized in chloroform/methanol (2:1, vol/vol) and
extracted successively in chloroform/methanol (2:1 and 1:2, vol/vol).
Total lipids were treated with 0.1 mol/L NaOH in methanol for 2 hours
at 40°C, neutralized with 0.35 mol/L acetic acid, and evaporated. The
dry residue was dissolved in water and dialyzed against distilled water
for 48 hours at 4°C. After evaporation, lipids were dissolved in 50
mL chloroform/methanol/water (30:60:8, vol/vol/vol) and applied to a
column (1.5x20 cm) packed with DEAE–Sephadex A-25 (40 to 100 mesh,
Pharmacia Fine Chemicals) in acetate form.33 Neutral GSLs
were eluted with the same solvent mixture as the one the lipids were in
when applied to the column. Gangliosides were eluted with
chloroform/methanol/0.8 mol/L ammonium acetate (30:60:8, vol/vol/vol).
After evaporation of elution solvent, gangliosides were dissolved in
water and dialyzed against distilled water for 48 hours at 4°C.
Neutral GSLs were subsequently purified through Silica Gel L 40/100
(Chemapol) column chromatography as follows: The GSL
samples were loaded on a silica gel column (6x150 mm, 3 g) in
chloroform. The column was washed with chloroform, and neutral GSLs
were eluted with chloroform/methanol/water (65:25:4, vol/vol/vol).
GSLs were isolated from cells as described earlier.10 11 Washed cell pellets were resuspended in 2 mL chloroform/methanol/water (5:5:1, vol/vol/vol) and sonicated. Lipid extraction was carried out for 2 hours at 22°C. The residue was pelleted, and the extraction was repeated twice more. Extracts were combined, evaporated, dissolved in 1 mL chloroform/methanol (2:1, vol/vol), and hydrolyzed for 20 minutes at 22°C after addition of 10 µL 10N HCl.34 Two milliliters of 0.5N NaOH dissolved in methanol was added to the hydrolyzate and incubated for 2 hours at 40°C. After evaporation, the precipitate was dissolved in a small volume of water, neutralized with 1N HCl, and desalted by use of a Sep-Pak C18 cartridge (Waters Associates).35 GSLs were then fractionated into acidic and neutral fractions on a 10x50-mm DEAE–Sephadex A-25 column, and neutral GSLs were subsequently purified through Silica Gel L 40/100 as described above.
Quantification of GSLs
Gangliosides were separated on high-performance
thin-layer chromatography plates of Silica Gel 60
(E. Merck). A mixture of chloroform/methanol/0.2% CaCl2
(55:45:10, vol/vol/vol) was used for ganglioside separation. Either
chloroform/methanol/water (65:25:4, vol/vol/vol) or
chloroform/methanol/0.2% CaCl2 (50:40:6, vol/vol/vol) was
used to separate neutral GSLs. Quantitative analysis of GSLs
was carried out on chromatography plates (after
visualization with resorcinol reagent for gangliosides and orcinol
reagent for neutral GSLs) with scanning densitometry on a PMQ-3
microspectrophotometer (Carl Zeiss) at a wavelength of 580 nm for
gangliosides36 and 515 nm for neutral GSLs.37
GSLs isolated from human aorta and previously
characterized8 9 were used as standards.
Statistical Analysis
Multivariate comparison of GSL content in normal
and atherosclerotic tissues was performed with MANOVA. Probability
values of less than .05 were considered significant.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Ganglioside Content in the Aortic Tissue
GM3 was a major ganglioside in all aortic layers, accounting for 70% to 95% of the ganglioside content (Figs 1A
and 2). GM3 content in the
hyperplastic layer of the plaque intima was 12-fold higher than in
normal regions (P<.05). Also, the level of GM3
in the muscular layer of plaque was 2.5-fold higher than in normal
tissue. GM1 and GD1a gangliosides were
present in the hyperplastic layer of plaque but were present at
lower levels in unaffected intimal hyperplastic regions. However,
GM1 and GD1a gangliosides, which were low in
normal hyperplastic intima, were more abundant in normal muscular
intima and normal media. The difference between the media and the
muscular layer of normal intima was that the muscular layer had a
higher level of GD3. At the same time, the muscular layer
of fatty streaks had an unexpectedly low content of all gangliosides
compared with unlesioned regions. The media underlying lesioned regions
showed a twofold to threefold increase in the content of gangliosides
GD3 (P<.05) and GD1a compared with
the media of unlesioned aorta.
|
|
The changes in the relative concentration of gangliosides in both
intimal layers show an increase in the percentage of GM3
and a decrease in the percentage of more complex gangliosides in the
direction from normal to fatty streak to plaque (Table 1). In contrast, the relative concentrations of
gangliosides in the media show a decrease in the percentage of
GM3 and an increase in the percentage of GD3
and GD1a in the direction from normal to fatty streak to
plaque. Such changes probably reflect the changes in function of these
tissues in the course of development of atherosclerotic lesions.
|
The media and intimal muscular layer contained two additional
gangliosides. The first had a chromatographic mobility
corresponding to the mobility of ganglioside GD1b from
bovine brain. The second was visualized lower than GM3 and
higher than GM1 on the chromatogram in Fig 1A
. This is
likely to be the ganglioside sialylparagloboside, and its presence in
smooth muscle cells and leukocytes has been shown
elsewhere.38 39 Unfortunately, we were not able to isolate
the above-mentioned gangliosides from the human aorta in sufficient
quantity to confirm their chemical structure.
Neutral GSL Content in Aortic Tissue
GbOse3Cer and GbOse4Cer were the main
neutral GSLs in normal intima and media (Figs 1B and 3).
Both the media and muscular layer of intima differed from the
hyperplastic layer of intima by their high levels of
GbOse3Cer and GbOse4Cer. However, much higher
amounts of GlcCer and LacCer were detected in muscular and hyperplastic
layers of atherosclerotic intimal tissues compared with normal intimal
tissues (significantly different for hyperplastic layer,
P<.05). The differences in the GbOse3Cer and
GbOse4Cer content of normal and lesioned intimal tissues
were not significant. The changes in the relative concentrations of
neutral GSLs in intimal layers show a general tendency of increase in
the concentration of simple GSLs (GlcCer and LacCer) from normal to
fatty streak to plaque and a decrease in the concentration of complex
GSLs (GbOse3Cer and GbOse4Cer) in these same
aortic tissues (Table 2). Neutral GSL content was
virtually unchanged in lesioned and normal regions of the media.
|
|
Comparative Analysis of GSL Content in Aortic Cells
and Tissues
Table 3 shows the contents of GlcCer, LacCer, and
ganglioside GM3, the major GSLs that accumulate in
the cells and tissue of the intimal hyperplastic layer of
atherosclerotic plaques. Because normal intima cells contain little
GlcCer and LacCer, we did not previously succeed in quantifying GlcCer
and LacCer in these cells because of the insufficient numbers of cells
used for the analysis.11 In the present study
we isolated 10 times more cells for analysis, which made it
possible to quantify GlcCer and LacCer in cells isolated from normal
regions of aorta. Table 3 shows that the increase in GlcCer, LacCer,
and GM3 content in the atherosclerotic plaque tissue
compared with unaffected intimal tissue was considerably greater than
the increase in these GSLs in the cells isolated from similar
atherosclerotic plaque and normal intimal tissues. Thus, it can be
concluded that the rate of extracellular accumulation of GSLs is higher
than the rate of intracellular accumulation of GSLs.
|
GSL Composition of Extracellular Aortic Lipid
Particles
To elucidate a possible location of extracellular GSLs, we have
studied the GSL content of the two types of extracellular lipid
particles (one enriched in unesterified cholesterol, the
other enriched in esterified cholesterol) that can be
isolated from atherosclerotic aortic intimal tissue, as reported
earlier.21 More than 80% of cholesterol was
unesterified in unesterified cholesterol–rich lipid
particles and more than 80% of cholesterol was esterified
in esterified cholesterol–rich lipid particles.
Tables 4 and 5 show the GSL content of
aortic lipid particles, plasma LDLs isolated from patients with
documented coronary artery disease, and cells isolated from the
hyperplastic layer of atherosclerotic plaques. Unesterified
cholesterol–rich lipid particles exhibited a higher
content of neutral GSLs and GM3 compared with LDLs and a
higher content of GlcCer, LacCer, and GM3 compared with
intimal cells. A high content of GlcCer and a lower content of
GM3 differentiated the GSL composition of the esterified
cholesterol–rich lipid particles from that of LDLs.
The GlcCer content of the esterified cholesterol–rich
lipid particles was greater than the level observed in intimal cells.
The content of most other GSLs in esterified
cholesterol–rich lipid particles approximated that in
LDLs. The molar composition of GSLs in each type of aortic lipid
particles was constant for the samples of lipid particles prepared from
the three different aortas (data not shown). The molar composition
showed that GlcCer was relatively enriched in the aortic lipid
particles compared with aortic intimal cells. The opposite was true for
GbOse4Cer.
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Only a few studies have previously focused on elevated GSL content in atherosclerotic lesions, and these studies did not examine GSL content in defined layers of lesions.4 5 6 7 Therefore, the present investigation, together with our previous studies,8 9 10 11 can be regarded as the first detailed quantitative study on GSL accumulation in atherosclerotic aorta. The first finding is that ganglioside compositions of media and the hyperplastic (most luminal) layer of intima in grossly unaffected regions are different. The media contains much more GM1 and GD1a than the hyperplastic layer of intima. These gangliosides are more typical of nervous tissue, and their presence in the media may reflect electrical conduction within the media. This difference in ganglioside composition also raises the question as to whether intimal SMCs change their ganglioside composition when migrating from the media into the intima during the thickening of aorta vessel wall. Alternatively, possibly most intimal cells within the hyperplastic layer do not originate from medial SMCs. At the same time, the similarity of ganglioside composition of the normal media to that in the normal muscular layer but not that in the normal hyperplastic layer suggests that the muscular layer is occupied by SMCs less dedifferentiated than the SMCs in the hyperplastic layer.
GlcCer and LacCer are very low in comparison to other GSLs in normal intima but increase in atherosclerotic intima. We have observed a great variability of the content of all GSLs with the exception of GlcCer, LacCer, and GM3 in intimal tissue. This could be due to either individual variation or peculiarities of the atherosclerosis development process. Nevertheless, the tendency of GlcCer and LacCer as well as GM3 to accumulate in atherosclerotic lesions is evident. There is a decreased content of total gangliosides in the muscular layer of fatty streaks compared with unlesioned tissue and atherosclerotic plaque. This result agrees with our previous findings of ganglioside content for cells of fatty streaks compared with cells of unlesioned regions and atherosclerotic plaque.10 However, whether loss of gangliosides reflects atherosclerosis development or some other factors needs to be clarified. The increased amount of GD3 with unchanged GM3 in the media underlying atherosclerotic lesions is interesting because of recently published data on stimulation of angiogenesis by a change in the GD3:GM3 ratio.40 41 Perhaps this change in the GD3:GM3 ratio reflects the process of angiogenesis that occurs in atherosclerotic lesions.42
Another question arising in connection with the data obtained is whether GSL accumulation in intimal atherosclerotic lesions reflects passive accumulation of LDLs in the aortic wall, as suggested by Hara and Taketomi,7 or is an active process reflecting both influx and metabolism of GSLs in the aortic wall. On one hand, some findings support the possibility that GSL accumulation only reflects accumulation of LDLs in the aortic wall. First, GSL and LDL accumulation occurs in intima rather than in media. Second, GlcCer, LacCer, and GM3 are the major GSLs of LDLs,43 44 45 46 and accumulation of these particular GSLs takes place in the intima. On the other hand, there are some findings inconsistent with this possibility. First, LDLs also contain a number of other GSLs (including GbOse3Cer, GbOse4Cer, GD3, and GT1b43 44 45 46 ) whose content did not increase in atherosclerotic lesions (in particular, gangliosides GD3 and GT1b). Second, aorta samples from donors about 50 years old were used in the experiments. The percentage of the total phospholipids and neutral lipid classes in such aortas is close to that of LDL lipids.47 Despite the rise in the lipid level in atherosclerotic lesions, the percentage of phospholipids and neutral lipid classes remains the same.25 In other words, accumulation of total phospholipids, triglycerides, cholesterol, and cholesteryl esters in the aortic wall is consistent with progressive accumulation of LDL lipid. At the same time, the GSL composition of normal and atherosclerotic regions of the aorta varies greatly. Therefore, the data suggest that if LDLs are the source of GSLs in atherosclerotic lesions, there is a selective accumulation of GlcCer, LacCer, and GM3 from the LDLs. If the GSL profile results from aortic wall metabolism, it is possible that aortic cells either should have synthesized those GSL species that accumulate in the aortic wall or should have excreted various glycosidases, which are able to convert more complex GSLs entering the wall together with LDLs into more simple GSLs such as GlcCer, LacCer, and GM3.
The secondary elastic lamina that separates hyperplastic and muscular layers of the intima has been demonstrated to be important in limiting the progression of atherosclerotic changes.48 Cells that occupy the hyperplastic layer differ from cells composing the muscular layer.49 We have shown earlier that the changes in the composition of neutral lipids and in the thickness of the intima are mainly confined to the hyperplastic layer.25 In contrast to those findings, the changes in ganglioside composition shown in the present study are more general, affecting to different degrees both layers of the intima and the media. However, the uneven distribution of GSLs in the aortic layers indicates a different involvement of GSL metabolism during atherogenesis in these layers.
A comparative analysis of the GSL content in the hyperplastic layer and cells isolated from the hyperplastic layer revealed that most GSLs accumulate in the extracellular space of the aorta. GSLs, like other lipids in a water phase, should tend either to form vesicles or to incorporate into vesicles or liposomes formed by other lipids in the extracellular space of the aorta. The results of the present study demonstrate that extracellular aortic lipid particles, identified by a number of investigators,12 13 14 15 16 17 18 19 20 21 are one locus of this extracellular GSL accumulation (another possible locus for the accumulation of GSLs could be the plasma membranes of cells surrounding extracellular lipid particles). As demonstrated previously, aortic lipid particles appear in the aorta in a prelesional stage of atherogenesis.16 17 18 Thus, the accumulation of GSLs in the aorta, in addition to the accumulation of cholesterol, may prove to be an early biochemical event in the development of the atherosclerotic lesion.
Both types of lipid particles that can be isolated from the aorta, unesterified cholesterol–rich multilamellar liposomes and esterified cholesterol–rich droplets,21 contained GSLs. Previous chemical analysis indicates that the extracellular esterified cholesterol–rich lipid particles could be derived from extracellular deposition of LDLs.15 Chao et al50 have shown that unesterified cholesterol–rich multilamellar liposomes can be produced from LDLs with enzymatic hydrolysis of their cholesteryl ester core. It is possible that unesterified cholesterol–rich multilamellar particles are derived from LDLs, but only after LDLs have been processed by aortic cells. Schmitz, Robenek, and coworkers51 52 have shown that cholesterol-rich particles of this type can be secreted by cholesterol-rich macrophages after uptake of acetylated LDLs. However, the generally high content of GlcCer and GM3 detected in these particles in comparison to that in LDLs suggests that if these particles are derived from LDLs they must also acquire GlcCer from some other source. The concentration of GSLs in the cholesterol-rich aortic lipid particles may be determined by the availability of different GSLs through local synthesis within the blood vessel wall. There is a factor, in addition to synthesis of GSLs by vascular cells, that could influence the GSL profiles found associated with the isolated aortic lipid particles. The distribution of GSLs in these particles may reflect differences in association of various GSLs with other types of lipids depending on their hydrophobicity.
GSL accumulation in the aortic wall is very likely to be related to the phenomenon of sphingomyelin accumulation in the aortic wall during atherosclerosis.53 In addition to aortic lipid particles' content of cholesterol and GlcCer, sphingomyelin is the predominant phospholipid in these particles.21 Thus, these aortic lipid particles provide another example of the coaccumulation of cholesterol, sphingomyelin, and GSLs. There are some data available demonstrating that sphingolipid biosynthesis is closely associated with intracellular cholesterol metabolism.54 55 56 57 An association between the accumulation of cholesterol and GSLs has been observed in tissues of patients afflicted with the various genetic variants of Niemann-Pick disease.58 In this disease, unesterified cholesterol, sphingomyelin, and mainly GlcCer accumulate in tissues. However, further investigation is needed to elucidate the relationship between GSL and cholesterol accumulation during atherosclerosis.
The present study demonstrates the accumulation of GSLs in the atherosclerotic human aorta. The majority of GSL accumulates in the extracellular space of intima, and extracellular lipid particles are one locus of this extracellular GSL accumulation. The absolute level and relative distribution of GSLs within atherosclerotic and nonatherosclerotic regions and within different layers, as well as within isolated aortic lipid particles, probably reflect a number of factors that include (1) synthesis of GSLs within the vessel wall, (2) deposition of GSLs within the vessel wall from plasma-derived lipoproteins, (3) the degree of association of the various GSLs with intimal cells as well as extracellular lipid particles, and (4) metabolic relationships between cholesterol and GSL accumulation. GSLs present in the extracellular space could interact with vessel wall cells either by means of exchange between the lipid particles and intimal cell membranes59 or by uptake of the extracellular lipid particles by the intimal cells. As a result of such interactions, GSLs could potentially influence processes important in the development of atherosclerotic lesions. For example, exogenous LacCer stimulates the proliferation of SMCs,60 and can, like gangliosides, activate alternative complement pathways.61 62 Exogenous gangliosides, in turn, could interact with LDL particles, influencing their structure and resulting in their aggregation.63 Exogenous GM3 has been shown to influence the uptake of LDLs by peritoneal mouse macrophages and to enhance cholesterol accumulation in these macrophages.64 Gangliosides can favor the adherence, spreading, and aggregation of platelets.65 GSLs are known to influence cell growth and differentiation, transmembrane signaling, and cellular interactions.66 In addition, enhanced expression of GM3 in human aorta was recently shown to correlate with the process of calcification.67 One may assume that these properties of GSLs should influence atherosclerotic lesion development. Further investigation should be followed to study the relationship between changes in GSL composition in the aortic wall and other features of atherosclerotic lesion development such as modifications of LDLs within the aortic wall, intracellular lipid accumulation, cell proliferation, angiogenesis, attraction of blood-borne cells, and changes in SMC phenotype from contractile to synthetic.
|
Selected Abbreviations and Acronyms |
|---|
|
|
Acknowledgments |
|---|
We thank Dr James Resau for providing some of the aortic tissue specimens and the USA-Russia Exchange Program in Cardiovascular Research for support of this work.
Received October 21, 1994; accepted July 13, 1995.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Anitschkow N, Chalatow S. On experimental cholesterin steatosis and its significance in the origin of some pathological processes. Arteriosclerosis. 1983;3:178-182.
2.
Quinn MT, Partharasathy S, Steinberg D.
Lysophosphatidylcholine: a chemotactic factor for human
monocytes and its potential role in atherogenesis. Proc
Natl Acad Sci U S A. 1988;85:2805-2809.
3. Wolf A, Saito T, Menon NK, Zehetgruber M, Bing RJ. Effect of lysophosphatidylcholine on atherosclerotic rabbit arteries. Atherosclerosis. 1989;80:81-89. [Medline] [Order article via Infotrieve]
4. Hausheer L, Bernhard K. Cerebroside aus menschlichen aorten.Z Physiol Chem. 1963;331:41-44.
5. Coles E, Foot JL. Glycosphingolipids from rabbit aorta, plasma, and red blood cells: effects of high cholesterol-high fat diets on fatty acid distribution and quantity of glycosphingolipids. J Lipid Res. 1974;15:192-199. [Abstract]
6. Breckenridge WC, Halloran JL, Kovacs K, Silver MD. Increase of gangliosides in atherosclerotic human aortas. Lipids. 1975;10:256-259.
7.
Hara A, Taketomi T. Characterization and
changes of glycosphingolipids in the aorta of the Watanabe hereditable
hyperlipidemic rabbit. J
Biochem (Tokyo). 1991;109:904-908.
8. Prokazova NV, Orekhov AN, Mukhin DN, Mikhailenko IA, Kogtev LS, Sadovskaya VL, Golovanova NK, Bergelson LD. The gangliosides of adult human aorta: intima, media and plaque. Eur J Biochem. 1987;167:349-352. [Medline] [Order article via Infotrieve]
9. Prokazova NV, Mukhin DN, Orekhov AN, Gladkaya EM, Vasilevskaya VV, Mikhailenko IA, Sadovskaya VL, Bushuev VN, Bergelson LD. Neutral glycolipids of atherosclerotic plaques and unaffected human aorta tissue. Eur J Biochem. 1989;180:167-171. [Medline] [Order article via Infotrieve]
10. Mukhin DN, Prokazova NV, Bergelson LD, Orekhov AN. Ganglioside content and composition of cells from normal and atherosclerotic human aorta. Atherosclerosis. 1989;78:39-45. [Medline] [Order article via Infotrieve]
11. Mukhin DN, Prokazova NV. Neutral glycosphingolipid content and composition of cells from normal and atherosclerotic human aorta. Atherosclerosis. 1992;93:173-177. [Medline] [Order article via Infotrieve]
12. Kruth HS. Histochemical detection of esterified cholesterol within human atherosclerotic lesion using the fluorescent probe, filipin. Atherosclerosis. 1984;51:281-292. [Medline] [Order article via Infotrieve]
13. Kruth HS. Localization of unesterified cholesterol in human atherosclerotic lesions: demonstration of filipin-positive, oil red O-negative particles. Am J Pathol. 1984;114:201-207. [Abstract]
14. Bocan TMA, Schifani TA, Guyton JR. Ultrastructure of the human aortic fibrolipid lesion: formation of the atherosclerotic lipid-rich core. Am J Pathol. 1984;123:413-424. [Abstract]
15. Smith EB, Evans PH, Downham MD. Lipid in the aortic intima: the correlation of morphological and chemical characteristics. J Atheroscler Res. 1967;7:171-186. [Medline] [Order article via Infotrieve]
16. Kruth HS. Subendothelial accumulation of unesterified cholesterol: an early event in atherosclerotic lesion development. Atherosclerosis. 1985;57:337-341. [Medline] [Order article via Infotrieve]
17. Simionescu N, Vasile E, Lupu H, Popescu G, Simionescu M. Prelesional events in atherogenesis: accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves on the hyperlipidemic rabbit. Am J Pathol. 1986;123:109-125. [Abstract]
18.
Nievelstein-Post P, Mottino G, Fogelman A, Frank J.
An ultrastructural study of lipoprotein accumulation in cardiac
valves of the rabbit. Arterioscler Thromb. 1994;14:1151-1161.
19. Chao FF, Amende LM, Blanchette-Mackie EJ, Skarlatos SI, Gamble W, Resau JH, Mergner WT, Kruth HS. Unesterified cholesterol-rich lipid particles in atherosclerotic lesions of human and rabbit aorta. Am J Pathol. 1988;131:73-83. [Abstract]
20. Mora R, Simionescu M, Simionescu N. Purification and partial characterization of extracellular liposomes isolated from the hyperlipidemic rabbit aorta. J Lipid Res. 1990;31:1793-1807. [Abstract]
21. Chao FF, Blanchette-Mackie EJ, Chen YJ, Dickens BF, Berlin E, Amende LM, Skarlatos SI, Gamble W, Resau JH, Mergner WT, Kruth HS. Characterization of two unique cholesterol-rich lipid particles isolated from human atherosclerotic lesion. Am J Pathol. 1990;136:169-179. [Abstract]
22. Smith EB. The relationship between plasma and tissue lipids in human atherosclerosis. Adv Lipid Res. 1974;12:1-49. [Medline] [Order article via Infotrieve]
23. Gross L, Epstein EZ, Kugel MD. Histology of the coronary arteries and their branches in the human heart. Am J Pathol. 1934;10:253-274.
24. Movat HZ, More RH, Haust MD. The diffuse intimal thickening of the human aorta with aging. Am J Pathol. 1958;34:1023-1031.
25. Mukhin DN, Orekhov AN, Andreeva ER, Schindeler EM, Smirnov VN. Lipids in cells of atherosclerotic and uninvolved human aorta, III: lipid distribution in intimal sublayers. Exp Mol Pathol. 1991;54:22-30. [Medline] [Order article via Infotrieve]
26. Leibovitz A. The growth and maintenance of tissue-cell cultures in free gas exchange with the atmosphere. Am J Hyg. 1963;78:173-180. [Medline] [Order article via Infotrieve]
27. Redgrave TG, Roberts DCK, West CE. Separation of plasma lipoproteins by density gradient ultracentrifugation. Anal Biochem. 1975;65:42-49. [Medline] [Order article via Infotrieve]
28. Lindgren FT. Preparative ultracentrifugal laboratory procedure and suggestions for lipoprotein analysis. In: Perkin EG, ed. Analysis of Lipid and Lipoproteins. New York, NY: American Oil Chemical Society; 1975:205-224.
29. Orekhov AN, Kosykh VA, Repin VS, Smirnov VN. Cell proliferation in normal and atherosclerotic human aorta, I: flow cytofluorometric determination of cellular deoxyribonucleic acid content. Lab Invest. 1983;48:395-398. [Medline] [Order article via Infotrieve]
30. Andreeva ER, Rekhter MD, Romanov YA, Antonova GM, Antonov AS, Mironov AA, Orekhov AN. Stellate cells of aortic intima, II: arborization of intimal cells in culture. Tissue Cell. 1992;24:697-704. [Medline] [Order article via Infotrieve]
31.
Folch J, Lees M, Stanley GHS. A simple method
for the isolation and purification of total lipids from animal
tissues. J Biol Chem. 1957;226:497-509.
32. Gamble W, Vaughan M, Kruth HS, Avigan J. Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells. J Lipid Res. 1978;19:1068-1070. [Abstract]
33.
Ohashi M. A new type of ganglioside: the
structure of three novel gangliosides from fat body of frog.
J Biochem (Tokyo). 1980;88:583-589.
34. Byrne MC, Sbaschnig-Agler M, Aquino DA, Sclafani JP, Ledeen RW. Procedure for isolation of gangliosides in high yield and purity: simultaneous isolation of neutral glycosphingolipids. Anal Biochem. 1985;148:163-173. [Medline] [Order article via Infotrieve]
35. Williams MA, McCluer RH. The use of Sep-Pak C18 cartridge during the isolation of gangliosides. J Neurochem. 1980;35:266-269. [Medline] [Order article via Infotrieve]
36. Ando S, Chang NC, Yu RK. High-performance thin-layer chromatography and densitometric determination of brain ganglioside composition of several species. Anal Biochem. 1978;89:437-450. [Medline] [Order article via Infotrieve]
37. Rosengren B, Mansson JF, Svennerholm L. Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay-Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease? J Neurochem. 1987;49:834-840. [Medline] [Order article via Infotrieve]
38. Gillard BK, Jones MA, Marcus DM. Glycosphingolipids of human umbilical vein endothelial cells and smooth muscle cells. Arch Biochem Biophys. 1987;256:435-445. [Medline] [Order article via Infotrieve]
39.
Kiguchi K, Henning-Chubb CB, Huberman E.
Glycosphingolipid patterns of peripheral blood
lymphocytes, monocytes, and granulocytes are cell specific.
J Biochem (Tokyo). 1990;107:8-14.
40. Ziche M, Alessandri G, Gullino PM. Gangliosides promote the angiogenic response. Lab Invest. 1989;61:629-634. [Medline] [Order article via Infotrieve]
41. Ziche M, Morbidelli L, Alessandri G, Gullino PM. Angiogenesis can be stimulated or repressed in vivo by a change in GM3:GD3 ganglioside ratio. Lab Invest. 1992;67:711-715. [Medline] [Order article via Infotrieve]
42. Eisenstein R. Angiogenesis in arteries: review. Pharmacol Ther. 1991;49:1-19. [Medline] [Order article via Infotrieve]
43. Clarke JTR. The glycosphingolipids of human plasma lipoproteins. Can J Biochem. 1981;59:412-417. [Medline] [Order article via Infotrieve]
44. Chatterjee S, Kwiterovich PO Jr. Glycosphingolipids and plasma lipoproteins: a review. Can J Biochem. 1984;62:385-397.
45. Kundu SK, Diego L, Osovitz S, Marcus DM. Glycosphingolipids of human plasma. Arch Biochem Biophys. 1985;238:388-400. [Medline] [Order article via Infotrieve]
46. Senn HJ, Orth M, Fitzke E, Wieland H, Gerok W. Gangliosides in normal human serum: concentration, pattern and transport by lipoproteins. Eur J Biochem. 1989;181:657-662. [Medline] [Order article via Infotrieve]
47.
Katz SS. The lipids of grossly normal human
aortic intima from birth to old age. J Biol
Chem. 1981;256:12275-12280.
48. Sims FH, Chen X, Gavin JB. The importance of a substantial elastic lamina subjacent to the endothelium in limiting the progression of atherosclerotic changes. Histopathology. 1993;23:307-317. [Medline] [Order article via Infotrieve]
49. Rekhter MD, Andreeva ER, Mironov AA, Orekhov AN. Three-dimensional cytoarchitecture of normal and atherosclerotic intima of human aorta. Am J Pathol. 1991;138:569-580. [Abstract]
50.
Chao FF, Blanchette-Mackie EJ, Tertov VV, Skarlatos SI,
Chen YJ, Kruth HS. Hydrolysis of cholesteryl ester in low
density lipoprotein converts this lipoprotein to a liposome.
J Biol Chem. 1992;267:4992-4998.
51.
Schmitz G, Robenek H, Beuck M, Krause R, Schurek A,
Niemann R. Ca++ antagonists and ACAT
inhibitors promote cholesterol efflux from
macrophages by different mechanisms, I: characterization of
cellular lipid metabolism.
Arteriosclerosis. 1988;8:46-56.
52.
Robenek H, Schmitz G. Ca++
antagonists and ACAT inhibitors promote
cholesterol efflux from macrophages by different
mechanisms, II: characterization of intracellular morphologic
changes. Arteriosclerosis. 1988;8:57-67.
53. Barenholz Y, Gatt S. Sphingomyelin: metabolism, chemical synthesis, chemical and physical properties. In: Hawthorne JN, Ansell GB, eds. Phospholipids. Amsterdam, the Netherlands: Elsevier Biomedical Press; 1982:161-163.
54.
Kwok BCP, Dawson G, Ritter MC. Stimulation of
glycolipid synthesis and exchange by human serum high density
lipoprotein-3 in human fibroblasts and leukocytes.
J Biol Chem. 1981;256:92-98.
55.
Verdery RB III, Theolis R Jr. Regulation of
sphingomyelin long chain base synthesis in human fibroblasts in
culture. J Biol Chem. 1982;257:1412-1417.
56.
Chatterjee S, Clarke KS, Kwiterovich PO Jr.
Regulation of synthesis of lactosylceramide and long chain bases
in normal and familial hypercholesterolemic
cultured proximal tubular cells. J Biol
Chem. 1986;261:13474-13479.
57. Schmitz G, Beuck M, Fischer H, Nowicka G, Robenek H. Regulation of phospholipid biosynthesis during cholesterol influx and high density lipoprotein-mediated cholesterol efflux in macrophages. J Lipid Res. 1990;31:1741-1752. [Abstract]
58. Vanier MT. Biochemical studies in Niemann-Pick disease, I: major sphingolipids of liver and spleen. Biochim Biophys Acta. 1983;750:178-184. [Medline] [Order article via Infotrieve]
59. Thompson TE, Tillack TW. Organization of glycosphingolipids in bilayers and plasma membranes of mammalian cells. Annu Rev Biophys Biophys Chem. 1985;14:361-386. [Medline] [Order article via Infotrieve]
60. Chatterjee S. Lactosylceramide stimulates aortic smooth muscle cell proliferation. Biochem Biophys Res Commun. 1991;181:554-561. [Medline] [Order article via Infotrieve]
61. Okada N, Yasuda T, Okada H. Restriction of alternative complement pathway activation by sialosylglycolipids. Nature. 1982;299:261-263. [Medline] [Order article via Infotrieve]
62.
Oshima H, Soma G, Mizuno D. Gangliosides can
activate human alternative complement pathway.
Int Immunol. 1993;5:1349-1351.
63. Mikhailenko IA, Dubrovskaya SA, Korepanova OB, Timofeeva NG, Morozkin AD, Prokazova NV, Bergelson LD. Interaction of low-density lipoproteins with gangliosides. Biochim Biophys Acta. 1991;1085:299-305. [Medline] [Order article via Infotrieve]
64. Prokazova NV, Mikhailenko IA, Bergelson LD. Ganglioside GM3 stimulates the uptake and processing of low density lipoproteins by macrophages. Biochem Biophys Res Commun. 1991;177:582-587. [Medline] [Order article via Infotrieve]
65. Mazurov AV, Prokazova NV, Mikhailenko IA, Mukhin DN, Repin VS, Bergelson LD. Stimulation of platelet adhesion and activation by ganglioside GD3 absorbed to plastic. Biochim Biophys Acta. 1988;968:167-171. [Medline] [Order article via Infotrieve]
66.
Hakomori S. Bifunctional role of
glycosphingolipids. J Biol Chem. 1990;265:18713-18716.
67. Watson KE, Boström K, Ravindranath R, Lam T, Norton B, Demer LL. TGF-ß1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest. 1994;93:2106-2113.
This article has been cited by other articles:
 |
|
 |
|
  H. Mu, X. Wang, H. Wang, P. Lin, Q. Yao, and C. Chen Lactosylceramide promotes cell migration and proliferation through activation of ERK1/2 in human aortic smooth muscle cells Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H400 - H408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. N. Glaros, W. S. Kim, K.-A. Rye, J. A. Shayman, and B. Garner Reduction of plasma glycosphingolipid levels has no impact on atherosclerosis in apolipoprotein E-null mice J. Lipid Res., August 1, 2008; 49(8): 1677 - 1681. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Waldo, Y. Li, C. Buono, B. Zhao, E. M. Billings, J. Chang, and H. S. Kruth Heterogeneity of Human Macrophages in Culture and in Atherosclerotic Plaques Am. J. Pathol., April 1, 2008; 172(4): 1112 - 1126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. N. Glaros, W. S. Kim, C. M. Quinn, W. Jessup, K.-A. Rye, and B. Garner Myriocin slows the progression of established atherosclerotic lesions in apolipoprotein E gene knockout mice J. Lipid Res., February 1, 2008; 49(2): 324 - 331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-K. Moon, S.-K. Kang, and C.-H. Kim Reactive oxygen species mediates disialoganglioside GD3-induced inhibition of ERK1/2 and matrix metalloproteinase-9 expression in vascular smooth muscle cells FASEB J, July 1, 2006; 20(9): 1387 - 1395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. N. Glaros, W. S. Kim, C. M. Quinn, J. Wong, I. Gelissen, W. Jessup, and B. Garner Glycosphingolipid Accumulation Inhibits Cholesterol Efflux via the ABCA1/Apolipoprotein A-I Pathway: 1-PHENYL-2-DECANOYLAMINO-3-MORPHOLINO-1-PROPANOL IS A NOVEL CHOLESTEROL EFFLUX ACCELERATOR J. Biol. Chem., July 1, 2005; 280(26): 24515 - 24523. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. F. Bodary, Y. Shen, F. B. Vargas, X. Bi, K. A. Ostenso, S. Gu, J. A. Shayman, and D. T. Eitzman {alpha}-Galactosidase A Deficiency Accelerates Atherosclerosis in Mice With Apolipoprotein E Deficiency Circulation, February 8, 2005; 111(5): 629 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Major, M. T. Wilson, J. L. McCaleb, Y. Ru Su, A. K. Stanic, S. Joyce, L. Van Kaer, S. Fazio, and M. F. Linton Quantitative and Qualitative Differences in Proatherogenic NKT Cells in Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2351 - 2357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-K. Moon, H.-M. Kim, Y.-C. Lee, and C.-H. Kim Disialoganglioside (GD3) Synthase Gene Expression Suppresses Vascular Smooth Muscle Cell Responses via the Inhibition of ERK1/2 Phosphorylation, Cell Cycle Progression, and Matrix Metalloproteinase-9 Expression J. Biol. Chem., August 6, 2004; 279(32): 33063 - 33070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Khovidhunkit, M.-S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host J. Lipid Res., July 1, 2004; 45(7): 1169 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Bhunia, G. Schwarzmann, and S. Chatterjee GD3 Recruits Reactive Oxygen Species to Induce Cell Proliferation and Apoptosis in Human Aortic Smooth Muscle Cells J. Biol. Chem., May 3, 2002; 277(19): 16396 - 16402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Garner, D. A. Priestman, R. Stocker, D. J. Harvey, T. D. Butters, and F. M. Platt Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice J. Lipid Res., February 1, 2002; 43(2): 205 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-Q. Wen, A. A. Jabbar, D. A. Patel, T. Kazarian, and L. A. Valentino Atherosclerotic Aortic Gangliosides Enhance Integrin-Mediated Platelet Adhesion to Collagen Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 519 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Bhunia, T. Arai, G. Bulkley, and S. Chatterjee Lactosylceramide Mediates Tumor Necrosis Factor-alpha -induced Intercellular Adhesion Molecule-1 (ICAM-1) Expression and the Adhesion of Neutrophil in Human Umbilical Vein Endothelial Cells J. Biol. Chem., December 18, 1998; 273(51): 34349 - 34357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chatterjee Sphingolipids in Atherosclerosis and Vascular Biology Arterioscler. Thromb. Vasc. Biol., October 1, 1998; 18(10): 1523 - 1533. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Memon, W. M. Holleran, A. H. Moser, T. Seki, Y. Uchida, J. Fuller, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold Endotoxin and Cytokines Increase Hepatic Sphingolipid Biosynthesis and Produce Lipoproteins Enriched in Ceramides and Sphingomyelin Arterioscler. Thromb. Vasc. Biol., August 1, 1998; 18(8): 1257 - 1265. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||